HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterizing the cancer genome in lung adenocarcinoma.

Abstract
Somatic alterations in cellular DNA underlie almost all human cancers. The prospect of targeted therapies and the development of high-resolution, genome-wide approaches are now spurring systematic efforts to characterize cancer genomes. Here we report a large-scale project to characterize copy-number alterations in primary lung adenocarcinomas. By analysis of a large collection of tumours (n = 371) using dense single nucleotide polymorphism arrays, we identify a total of 57 significantly recurrent events. We find that 26 of 39 autosomal chromosome arms show consistent large-scale copy-number gain or loss, of which only a handful have been linked to a specific gene. We also identify 31 recurrent focal events, including 24 amplifications and 7 homozygous deletions. Only six of these focal events are currently associated with known mutations in lung carcinomas. The most common event, amplification of chromosome 14q13.3, is found in approximately 12% of samples. On the basis of genomic and functional analyses, we identify NKX2-1 (NK2 homeobox 1, also called TITF1), which lies in the minimal 14q13.3 amplification interval and encodes a lineage-specific transcription factor, as a novel candidate proto-oncogene involved in a significant fraction of lung adenocarcinomas. More generally, our results indicate that many of the genes that are involved in lung adenocarcinoma remain to be discovered.
AuthorsBarbara A Weir, Michele S Woo, Gad Getz, Sven Perner, Li Ding, Rameen Beroukhim, William M Lin, Michael A Province, Aldi Kraja, Laura A Johnson, Kinjal Shah, Mitsuo Sato, Roman K Thomas, Justine A Barletta, Ingrid B Borecki, Stephen Broderick, Andrew C Chang, Derek Y Chiang, Lucian R Chirieac, Jeonghee Cho, Yoshitaka Fujii, Adi F Gazdar, Thomas Giordano, Heidi Greulich, Megan Hanna, Bruce E Johnson, Mark G Kris, Alex Lash, Ling Lin, Neal Lindeman, Elaine R Mardis, John D McPherson, John D Minna, Margaret B Morgan, Mark Nadel, Mark B Orringer, John R Osborne, Brad Ozenberger, Alex H Ramos, James Robinson, Jack A Roth, Valerie Rusch, Hidefumi Sasaki, Frances Shepherd, Carrie Sougnez, Margaret R Spitz, Ming-Sound Tsao, David Twomey, Roel G W Verhaak, George M Weinstock, David A Wheeler, Wendy Winckler, Akihiko Yoshizawa, Soyoung Yu, Maureen F Zakowski, Qunyuan Zhang, David G Beer, Ignacio I Wistuba, Mark A Watson, Levi A Garraway, Marc Ladanyi, William D Travis, William Pao, Mark A Rubin, Stacey B Gabriel, Richard A Gibbs, Harold E Varmus, Richard K Wilson, Eric S Lander, Matthew Meyerson
JournalNature (Nature) Vol. 450 Issue 7171 Pg. 893-8 (Dec 06 2007) ISSN: 1476-4687 [Electronic] England
PMID17982442 (Publication Type: Journal Article)
Chemical References
  • Intracellular Signaling Peptides and Proteins
  • MAS1 protein, human
  • MBIP protein, human
  • NKX2-1 protein, human
  • Nuclear Proteins
  • Proto-Oncogene Mas
  • Thyroid Nuclear Factor 1
  • Transcription Factors
Topics
  • Adenocarcinoma (genetics)
  • Cell Line, Tumor
  • Chromosome Deletion
  • Chromosomes, Human, Pair 14 (genetics)
  • Gene Amplification (genetics)
  • Genome, Human (genetics)
  • Genomics
  • Genotype
  • Humans
  • Intracellular Signaling Peptides and Proteins (genetics)
  • Loss of Heterozygosity (genetics)
  • Lung Neoplasms (genetics)
  • Neoplasms (genetics)
  • Nuclear Proteins (genetics)
  • Polymorphism, Single Nucleotide (genetics)
  • Proto-Oncogene Mas
  • RNA Interference
  • Thyroid Nuclear Factor 1
  • Transcription Factors (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: